EN
HI

Suraksha Diagnostic Share price

SURAKSHA

HealthcareSmall

321.1

6.50 (-1.98%)
NSE
BSE
Last updated on 30 May, 2025 | 15:47 IST
BUYSELL
Today's High

334.15

Today's Low

313.60

52 Week Low

231.00

52 Week High

449.00

The current prices are delayed, login to your account for live prices

Suraksha Diagnostic Chart

Suraksha Diagnostic Share Key Metrics

Volume
36471.00
Market Cap
1672.31 CR
LTQ@LTP
1@321.10
ATP
326.16
Var Margin
14.82 %
Circuit Range
262.1-393.1
Delivery %
61.89 %
Value
1.19 CR
ASM/GSM
No
Market Lot
1

Suraksha Diagnostic Futures & Options

Data Not Found

Suraksha Diagnostic Corporate Actions

DateAgenda
2025-05-28Audited Results & Final Dividend
2025-02-08Quarterly Results
DateEvent TypeAgenda
2025-05-28Board MeetingAudited Results & Final Dividend
2025-02-08Board MeetingQuarterly Results

Suraksha Diagnostic News

No Data Found

About Suraksha Diagnostic

NSE : 27334  
BSE : 544293  
ISIN : INE877V01027  

Our Company was incorporated as ‘Suraksha Diagnostic Private Limited’ as a private limited company under the Companies Act 1956 pursuant to a certificate of incorporation dated March 15 2005 issued by the Deputy Registrar of Companies West Bengal at Kolkata (“RoC”). Subsequently our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5 2024 and consequently the name of our Company was changed to ‘Suraksha Diagnostic Limited’ and a fresh certificate of incorporation dated July 16 2024 was issued by the Registrar of Companies Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur West Bengal.2010-Launched centre at Khardah West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited) and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town

Suraksha Diagnostic Management

NamePosition
Dr. Somnath Chatterjee Chairman & Jt. M. D
Ms. Ritu Mittal Joint Managing Director & CEO
Mr. Satish Kumar Verma Non Exe.Non Ind.Director
Mr. Arun Sadhanandham Nominee Director
Mr. Pradip Kumar Dutta Independent Director
Read More

Suraksha Diagnostic FAQs

The Buying Price of Suraksha Diagnostic share is 321.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Suraksha Diagnostic share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Suraksha Diagnostic shares is 52.96. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Suraksha Diagnostic shares is 7.98. Useful to assess the stock's value relative to its book value.

To assess Suraksha Diagnostic’s valuation compare Sector P/E, P/B which are 48.64 & 4.18 with sector averages, along with growth rates and financial metrics.

The Market Cap of Suraksha Diagnostic is 1672.31 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Suraksha Diagnostic share price is 449.00 & 231.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.